Abstract
Partial liquid ventilation therapy utilizing perfluorocarbons has been used for patients with severe respiratory distress. Perfluorocarbons such as perflubron have been demonstrated to clear from the lungs shortly after therapy. We present a 13-year-old boy with residual perflubron in his lungs, 12 years following therapy with perflubron. The imaging features are important to recognize as these patients return for additional care and imaging.
MeSH terms
-
Adolescent
-
Contrast Media / adverse effects
-
Extravasation of Diagnostic and Therapeutic Materials / diagnosis*
-
Extravasation of Diagnostic and Therapeutic Materials / etiology*
-
Extravasation of Diagnostic and Therapeutic Materials / prevention & control
-
Fluorocarbons / adverse effects*
-
Humans
-
Hydrocarbons, Brominated
-
Laryngostenosis / chemically induced*
-
Laryngostenosis / diagnosis*
-
Laryngostenosis / prevention & control
-
Liquid Ventilation
-
Male
Substances
-
Contrast Media
-
Fluorocarbons
-
Hydrocarbons, Brominated
-
perflubron